PPD-10558

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePPD-10558
Drug Alias NamePPD-10558RBx-10558
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsHypercholesterolemiaHyperlipidemiasMyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesActavis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFuriex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipidemiasMyalgia

Other Information

ATC CodeN/A
Related LinksN/A